(7-METHOXY-1H-INDOL-4-YL)BORONIC ACID PINACOL ESTER, 95.0%, 100mg

6-Chloro-2-iodo-4-methylpyridin-3-amine, 97%, 250mg

3-Aminoisoquinoline, 95.0%, 25g

5-Bromo-6'-chloro-[2,3']bipyridinyl, 97.0%, 2g

methyl 5-{[(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-carbamoyl-2,6-dimethylphenyl)-N-[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]propanamido]methyl}-2-methoxybenzoate, 98%, 100mg

(2-FLUORO-4-NITROPHENYL)(PIPERIDIN-1-YL)METHANONE, 95.0%, 250mg

Adamantane, 99.0%, 500g

2-(Difluoromethyl)-1,4-bis(trifluoromethyl)benzene, 98.0%, 5g

4-Chloro-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one, 95+%, 1g

2-Methyl-5-trifluoromethyl-2H-pyrazol-3-ylamine, 98.0%, 5g

(3-Nitro-pyrazol-1-yl)-acetic acid ethyl ester, 5g

Pointes de pipettes Mμlti® MiniFlex 0,1-10 μl, rondes, Boîte, Stérile, 200 Pièces

(1-(Tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl)boronic acid, 95+%, 100mg